Clinical Trials Logo

Arterial Occlusive Diseases clinical trials

View clinical trials related to Arterial Occlusive Diseases.

Filter by:

NCT ID: NCT00664963 Completed - Clinical trials for Arterial Occlusive Diseases

YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study

YUKON-BTK
Start date: April 2006
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effectiveness of the treatment with balloon-expandable YUKON-BTX-Sirolimus-eluting stent over the treatment with YUKON-BTX uncoated stent in patients with ischemic infrapopliteal arterial disease.

NCT ID: NCT00660634 Completed - Clinical trials for Intermittent Claudication

Angioplasty in Peripheral Arterial Disease and Endothelial Function

PTA-PAD-FMD
Start date: December 2004
Phase: Phase 4
Study type: Interventional

To investigate whether endovascular revascualrization of infrainguinal arterial obstructive disease has an effect on brachial artery reactivity

NCT ID: NCT00619788 Completed - Clinical trials for Peripheral Arterial Occlusive Disease

FeMoropopliteal AngioSculptâ„¢ SCoring BallOon CaTheter Study

MASCOT
Start date: March 2008
Phase: Phase 2/Phase 3
Study type: Interventional

This investigation is designed to demonstrate the efficacy and safety of the 4.0-5.0mm AngioSculpt Scoring Balloon Catheter (AngioScore, Inc.) for femoropopliteal use in a controlled clinical investigation. The scoring balloon is a semi-compliant balloon encircled by 3 spiral struts with a nitinol scoring element, which theoretically provides targeted scoring of lesions, by concentrating the dilation force thus minimizing barotrauma, elastic recoil and uncontrolled dissection. This may improve the outcome of the intervention and reduce the number of stents required.

NCT ID: NCT00617279 Terminated - Clinical trials for Peripheral Arterial Occlusive Disease

GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft

PRODIGY
Start date: December 2007
Phase: Phase 4
Study type: Interventional

The primary patency of the GORE PROPATEN Vascular Graft is equivalent to or better than disadvantaged autologous vein graft in an infragenicular peripheral bypass application at 12 months.

NCT ID: NCT00614848 Completed - Clinical trials for Coronary Artery Disease

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions

ENDEAVOR II
Start date: June 2003
Phase: N/A
Study type: Interventional

To demonstrate the safety and efficacy of the Driver Coronary Stent coated with 10 mcg/mm ABT-578 compared to the uncoated Driver Stent for the treatment of single de novo lesions in native coronary arteries 2.25-3.5 mm in diameter.

NCT ID: NCT00596752 Completed - Clinical trials for Peripheral Arterial Occlusive Disease

Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV

ESPECIAL
Start date: March 2004
Phase: Phase 4
Study type: Interventional

The study is to confirmatorily show a superior effect of Alprostadil compared to placebo on the rate of complete healing of ischemic necroses and ulcerations as well as on the frequency and height of major amputations in patients suffering from PAOD stage IV.

NCT ID: NCT00595257 Completed - Clinical trials for Arterial Occlusive Diseases

Feasability Study of Autologous Bone Marrow Aspirate Concentrate for Treatment of CLI

Start date: December 2007
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine if concentrated nucleated cells from your own bone marrow, injected or infused into an ischemic limb, will restore sufficient blood flow to avoid amputation.

NCT ID: NCT00593762 Suspended - Clinical trials for Peripheral Arterial Occlusive Disease

ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures

Start date: May 2005
Phase: N/A
Study type: Observational

The purpose of the study is to determine the response to aspirin (ASA) and Clopidogrel in patients with peripheral arterial occlusive disease (PAOD) requiring interventional procedures and to investigate if patients with "resistance" to ASA or Clopidogrel have an unfavourable outcome during long-term follow-up

NCT ID: NCT00566436 Active, not recruiting - Atherosclerosis Clinical Trials

Remote Endarterectomy Versus Suprageniculate Femoropopliteal Bypass

REVAS
Start date: October 2004
Phase: N/A
Study type: Interventional

The objective of this study is to compare remote superficial femoral artery endarterectomy with suprageniculate bypass surgery in the treatment of long occlusions of the superficial femoral artery. The study hypothesis is that patency rates are comparable and therefore the minimal invasive remote superficial femoral artery endarterectomy can be considered in patients presenting with a long occlusion of the superficial femoral artery.

NCT ID: NCT00537498 Completed - Diabetic Foot Clinical Trials

Urokinase Therapy in Diabetic Foot Syndrome

Start date: February 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate whether a treatment with urokinase (500 000 or 1 000 000 IU) can lead to ulcer-healing, lower rate of major amputation, and prolonged survival in patients with diabetic foot syndrome.